Venrock Healthcare Capital Partners III, L.P.

13F Holdings History for CytomX Therapeutics, Inc. - Common Stock, $0.00001 par value per share (CTMX)

Symbol: CTMX on Nasdaq
Investment type: Equity / Common Stock, $0.00001 par value per share
Latest Disclosed Ownership: 13M shares
Security Ownership: 8.2%

Venrock Healthcare Capital Partners III, L.P. ownership in CytomX Therapeutics, Inc. Common Stock, $0.00001 par value per share (CTMX)

2025-05-20 - Venrock Healthcare Capital Partners III, L.P. has filed an SCHEDULE 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 13M shares of CytomX Therapeutics, Inc. Common Stock, $0.00001 par value per share (CTMX). This represents 8.2% percent ownership of the company.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
Venrock Healthcare Capital Partners III, L.P.	8.2%		$9.22M	13M			$0.71	13G	5/13/2025	20 May 2025 16:25:54